Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms

15 May 2025

Abstract excerpt

Research on myeloid neoplasms, a field that has been driving scientific advances in cancer for over 50 years, has yielded many discoveries that have fundamentally reshaped our understanding of cancer biology. These insights, often the product of leukemia research, have been instrumental in developing more mechanism-based treatments in the early 2000s [1]. Recognizing epigenetic dysregulation as a common disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Epigenetics and DNA Methylation
Share to Histone Deacetylase Inhibitors Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40374809
DOI: 10.1038/s41375-025-02639-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasmsPMID 40374809Read ↗

Epigenetic regulators as promising therapeutic targets in acute myeloid leukemiaSemantic proximity Read ↗

Clinical developments in epigenetic-directed therapies in acute myeloid leukemiaSemantic proximity Read ↗

Recent advances in the understanding and treatment of acute myeloid leukemiaSemantic proximity Read ↗

Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and HeterogeneitySemantic proximity Read ↗

Epigenetic alterations in acute myeloid leukemiasSemantic proximity Read ↗

Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalitiesSemantic proximity Read ↗

Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemiaSemantic proximity Read ↗

Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid LeukemiaSemantic proximity Read ↗

Epigenetic deregulation in myeloid malignanciesSemantic proximity Read ↗

Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies.Semantic proximity Read ↗

Epigenetic regulators and their impact on therapy in acute myeloid leukemiaSemantic proximity Read ↗

Epigenetics in Hematological Malignancies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.